Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies
Listen now
Description
Did you know that different types of drug resistance to antibody-drug conjugates (ADCs) can develop at different sites in the same patient? How may this impact ADC sequencing? Credit available for this activity expires: 12/13/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999152?ecd=bdc_podcast_libsyn_mscpedu
More Episodes
Do you know the best way to manage your patients with newly diagnosed advanced ovarian cancer? Credit available for this activity expires: 4/23/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000702?ecd=bdc_podcast_libsyn_mscpedu
Published 04/25/24
Published 04/25/24
Join our expert panel as they discuss the role of Janus kinase (JAK) inhibitors in the treatment of axial spondyloarthritis (axSpA). Credit available for this activity expires: 4/24/25 Earn Credit / Learning Objectives & Disclosures:...
Published 04/25/24